Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Bladder Cancer

Free Subscription Articles published in PLoS One Retrieve available abstracts of 38 articles: HTML format

Single Articles

January 2026
1. FENG C, Chen G, Shu Y, Chen J, et al
   Resveratrol inhibits bladder cancer proliferation by targeting the AURKA/STAT3 axis: From computational analysis to experimental validation.
   PLoS One. 2026;21:e0342162.
   PubMed     Abstract available
   
   
   
2. SHEN J, Zhao Z, Li Z, Wang R, et al
   Bladder cancer-induced CVD mortality: Role of CAPG protein.
   PLoS One. 2026;21:e0338101.
   PubMed     Abstract available
   
   
   
3. CHEN J, Li B, Gan Y, Li P, et al
   TNFRSF17 as a complementary biomarker to PD-L1 for predicting the response to immunotherapy in urothelial bladder cancer.
   PLoS One. 2026;21:e0346131.
   PubMed     Abstract available
   
   
   
4. GUO D, Li X, Xu X, Chen X, et al
   The Physicochemical Synergy Effect of Nanosecond Pulsed Electric Fields (nsPEF) and cisplatin on reversing chemoresistance of bladder cancer.
   PLoS One. 2026;21:e0346699.
   PubMed     Abstract available
   
   
   
5. YANG Z, Ma J, Qiang Z, Xie W, et al
   A new target: AlkBH2 promotes bladder cancer by upregulation of inflammation.
   PLoS One. 2026;21:e0348059.
   PubMed     Abstract available
   
   
   
6. WANG H, Liu H, Sun F, Wu J, et al
   Integrating multi-omics and machine learning to decipher the molecular pathways of bisphenol a-associated lactylation-related genes driving bladder cancer.
   PLoS One. 2026;21:e0347134.
   PubMed     Abstract available
   
   
   
7. 
   Retraction: Does Occupational Exposure to Solvents and Pesticides in Association with Glutathione S-Transferase A1, M1, P1, and T1 Polymorphisms Increase the Risk of Bladder Cancer? The Belgrade Case-Control Study.
   PLoS One. 2026;21:e0349169.
   PubMed    
   
   
   January 2025
8. ZHANG C, Weimann A, Stolzenburg JU, Neuhaus J, et al
   Notch2/3-DLL4 interaction in urothelial cancer cell lines supports a tumorigenic role of Notch signaling pathways in bladder carcinoma.
   PLoS One. 2025;20:e0317709.
   PubMed     Abstract available
   
   
   
9. KONDO Y, Mihara T, Yoshikawa N, Echigo N, et al
   Preoperative antihypertensives and hypotension during bladder tumor resection with oral 5-aminolevulinic acid administration.
   PLoS One. 2025;20:e0319413.
   PubMed     Abstract available
   
   
   
10. LI YH, Ou YC, Tung MC, Lin YS, et al
    Gender disparities in bladder cancer: A population-based study on life expectancy and health spending in Asia.
    PLoS One. 2025;20:e0323803.
    PubMed     Abstract available
    
    
    
11. WANG B, Cao Z, Li Y, Zou H, et al
    Association between CYP17A1 rs743572 polymorphism and cancer risk: A meta-analysis.
    PLoS One. 2025;20:e0326843.
    PubMed     Abstract available
    
    
    
12. HU C, Wang F, Xu H, Dong X, et al
    Deep learning-based spatial analysis on tumor and immune cells of pathology images predicts MIBC prognosis.
    PLoS One. 2025;20:e0328816.
    PubMed     Abstract available
    
    
    
13. HSIEH KL, Huang KH, Chang CP, Tsai HW, et al
    CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells.
    PLoS One. 2025;20:e0331289.
    PubMed     Abstract available
    
    
    
14. KATO T, Okauchi N, Motegi T, Sakurai M, et al
    Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma.
    PLoS One. 2025;20:e0332825.
    PubMed     Abstract available
    
    
    
15. PARK Y, Xu W, Yang T, Hill V, et al
    STAG2 regulates polycomb and differentiation in urothelial precursors and bladder cancer.
    PLoS One. 2025;20:e0333128.
    PubMed     Abstract available
    
    
    
16. LLORT ASENS M, Khan I, Fagerholm SC
    beta2-integrins as biomarkers in urothelial cancer.
    PLoS One. 2025;20:e0326015.
    PubMed     Abstract available
    
    
    
17. VUORISTO L, Poyhonen A, Vuorlaakso SM, Kotsar A, et al
    Hyperglycemia and bladder cancer prognosis in a Finnish population-based cohort.
    PLoS One. 2025;20:e0338215.
    PubMed     Abstract available
    
    
    
18. FREY LJ, Banasiewicz KE, Ruckes C, Wagner I, et al
    Complications and oncologic outcome in bladder cancer patients receiving radical cystectomy after intravesical instillation treatment.
    PLoS One. 2025;20:e0337644.
    PubMed     Abstract available
    
    
    January 2024
19. KVIKSTAD V, Lillesand M, Gudlaugsson E, Mangrud OM, et al
    Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas.
    PLoS One. 2024;19:e0297141.
    PubMed     Abstract available
    
    
    
20. CHEN LC, Yang HJ, Yu BH, Lee MS, et al
    Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
    PLoS One. 2024;19:e0300391.
    PubMed     Abstract available
    
    
    
21. 
    Retraction: SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT.
    PLoS One. 2024;19:e0301572.
    PubMed    
    
    
    
22. PORTE F, Granghaud A, Chang J, Kearney M, et al
    Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.
    PLoS One. 2024;19:e0302548.
    PubMed     Abstract available
    
    
    
23. EMINAGA O, Lau H, Shkolyar E, Wardelmann E, et al
    Deep learning identifies histopathologic changes in bladder cancers associated with smoke exposure status.
    PLoS One. 2024;19:e0305135.
    PubMed     Abstract available
    
    
    
24. ZENG X, Luo D, Zhang S, Cui Z, et al
    High-dose radiation-induced immunogenic cell death of bladder cancer cells leads to dendritic cell activation.
    PLoS One. 2024;19:e0307024.
    PubMed     Abstract available
    
    
    
25. SHIN YS, Han K, Lee J, Han HH, et al
    Lymphatic embolization for early post-operative lymphatic leakage after radical cystectomy for bladder cancer.
    PLoS One. 2024;19:e0305240.
    PubMed     Abstract available
    
    
    
26. MARQUES M, Tezier M, Tourret M, Cazenave L, et al
    Risk factors for postoperative acute kidney injury after radical cystectomy for bladder cancer in the era of ERAS protocols: A retrospective observational study.
    PLoS One. 2024;19:e0309549.
    PubMed     Abstract available
    
    
    
27. CHEONG H, Yoo Y, Sung SH, Park S, et al
    Prognostic value of isolated tumor cells and micrometastasis of lymph nodes in invasive urinary bladder cancer.
    PLoS One. 2024;19:e0302445.
    PubMed     Abstract available
    
    
    January 2023
28. WEINBERG L, Aitken SAA, Kaldas P, Fletcher L, et al
    Postoperative complications and hospital costs following open radical cystectomy: A retrospective study.
    PLoS One. 2023;18:e0282324.
    PubMed     Abstract available
    
    
    
29. LIU CL, Tsai HW, Peng SL, Chang CP, et al
    CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma.
    PLoS One. 2023;18:e0281873.
    PubMed     Abstract available
    
    
    
30. SMITH-TOGOBO C, Mprah R, Yeboah EA, Anyidoho HK, et al
    Detection of cytological abnormalities in urothelial cells from individuals previously exposed or currently infected with Schistosoma haematobium.
    PLoS One. 2023;18:e0278202.
    PubMed     Abstract available
    
    
    
31. 
    Expression of Concern: The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
    PLoS One. 2023;18:e0284938.
    PubMed    
    
    
    
32. HAMID ARAH, Syadza YZ, Yausep OE, Christanto RBI, et al
    The expression of stem cells markers and its effects on the propensity for recurrence and metastasis in bladder cancer: A systematic review.
    PLoS One. 2023;18:e0269214.
    PubMed     Abstract available
    
    
    
33. VAINER G, Huang L, Emancipator K, Nuti S, et al
    Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
    PLoS One. 2023;18:e0285764.
    PubMed     Abstract available
    
    
    
34. SATO N, Mori KP, Sakai K, Miyata H, et al
    Exploring the mechanism of BK polyomavirus-associated nephropathy through consensus gene network approach.
    PLoS One. 2023;18:e0282534.
    PubMed     Abstract available
    
    
    
35. YUAN Q, Hu J, Yuan F, An J, et al
    Predictive role of pretreatment skeletal muscle mass index for long-term survival of bladder cancer patients: A meta-analysis.
    PLoS One. 2023;18:e0288077.
    PubMed     Abstract available
    
    
    
36. LEE J, Kim E, Park J, Choi S, et al
    Pre-analytical handling conditions and protein marker recovery from urine extracellular vesicles for bladder cancer diagnosis.
    PLoS One. 2023;18:e0291198.
    PubMed     Abstract available
    
    
    
37. LEONARDO K, Mirza H, Seno DH, Purnomo N, et al
    Transperitoneal vs extraperitoneal radical cystectomy: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0294809.
    PubMed     Abstract available
    
    
    
38. WANG E, Hagberg O, Malmstrom PU
    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
    PLoS One. 2023;18:e0292174.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum